TextbookRheumatology & Musculoskeletal

Rheumatology & Musculoskeletal

RA, SLE, vasculitis, crystal arthropathies, spondyloarthropathies, and connective tissue diseases with immunological investigations.

37 topics94 questions

P

Paget Disease of Bone

Focal disorder of accelerated bone remodelling resulting in disorganised, enlarged, and structurally weak bone. Most commonly affects the pelvis, spine, skull, and femur in older adults.

MRCP 1MRCP 2PLAB 1+3

Plantar Fasciitis

Common cause of heel pain due to degeneration and inflammation of the plantar fascia at its calcaneal insertion. Characterised by 'first-step' pain that improves with walking.

MRCP 1MRCP 2PLAB 1+3

Polyarteritis Nodosa

Necrotising vasculitis of medium-sized arteries with characteristic microaneurysm formation. Distinguished from ANCA-associated vasculitis by the absence of glomerulonephritis and ANCA negativity. Historically associated with hepatitis B, though idiopathic cases are now more common.

MRCP 1MRCP 2PLAB 1+3

Polymyalgia Rheumatica

Common inflammatory condition in older adults characterised by bilateral shoulder and hip girdle pain and stiffness with raised inflammatory markers. Responds dramatically to low-dose corticosteroids. Closely associated with giant cell arteritis (15-20% have coexistent GCA).

MRCP 1MRCP 2PLAB 1+3

Polymyositis

Idiopathic inflammatory myopathy characterised by symmetric proximal muscle weakness without the skin manifestations of dermatomyositis. CD8+ T-cell-mediated direct myofibre injury is the pathological hallmark. Now considered rare as many previously classified cases are reclassified as immune-mediated necrotising myopathy or inclusion body myositis.

MRCP 1MRCP 2PLAB 1+3

Pseudogout

Crystal arthropathy caused by calcium pyrophosphate dihydrate (CPPD) crystal deposition in joint cartilage and synovial fluid. Presents as acute monoarthritis mimicking gout, predominantly affecting the knee and wrist. Commonly affects elderly patients and is associated with osteoarthritis, hyperparathyroidism, and haemochromatosis.

MRCP 1MRCP 2PLAB 1+3

Psoriatic Arthritis

Inflammatory arthropathy associated with psoriasis, affecting up to 30% of psoriasis patients. Characterised by diverse patterns including peripheral arthritis, axial disease, dactylitis, and enthesitis. Distinguished from RA by DIP involvement, dactylitis, nail changes, and typical seronegativity.

MRCP 1MRCP 2PLAB 1+3

S

Septic Arthritis

Acute bacterial infection of a joint constituting an orthopaedic emergency. Most commonly caused by Staphylococcus aureus. Requires urgent joint aspiration and IV antibiotics to prevent irreversible cartilage destruction.

MRCP 1MRCP 2PLAB 1+3

Sjogren Syndrome

Chronic autoimmune condition characterised by lymphocytic infiltration and destruction of exocrine glands, particularly salivary and lacrimal glands, causing dry mouth (xerostomia) and dry eyes (keratoconjunctivitis sicca). Can be primary or secondary (associated with RA, SLE, or other autoimmune conditions). Carries a 5-10% lifetime risk of B-cell lymphoma.

MRCP 1MRCP 2PLAB 1+3

Spinal Stenosis

Narrowing of the spinal canal causing compression of the spinal cord or nerve roots, most commonly in the lumbar spine. Characterised by neurogenic claudication relieved by flexion/sitting.

MRCP 1MRCP 2PLAB 1+3

Systemic Lupus Erythematosus

Chronic, multisystem autoimmune disease characterised by autoantibody production (particularly anti-nuclear and anti-dsDNA antibodies) and immune complex deposition, causing inflammation in skin, joints, kidneys, brain, blood, and serosal surfaces. Predominantly affects women of childbearing age with increased prevalence in Afro-Caribbean and South Asian populations.

MRCP 1MRCP 2PLAB 1+3

Systemic Sclerosis

Chronic autoimmune connective tissue disease characterised by fibrosis of the skin and internal organs, vasculopathy, and immune activation. Classified as limited cutaneous (lcSSc, formerly CREST syndrome) or diffuse cutaneous (dcSSc). Anti-centromere antibodies associate with limited disease; anti-Scl-70 (anti-topoisomerase I) with diffuse disease.

MRCP 1MRCP 2PLAB 1+3
Rheumatology & Musculoskeletal Revision Notes | MedPrep